Ayawan, Jenilyn .

HRN: 18-06-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
CEFUROXIME 500MG (TAB)
01/31/2026
02/07/2026
PO
500mg
BID X 7 Days
Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: